Lexicon Pharmaceuticals/$LXRX
About Lexicon Pharmaceuticals
Ticker
Industry
Employees
LXRX Metrics
$255M
-
-$0.74
1.24
-
Price and volume
Market cap
$255M
Beta
1.24
52-week high
$3.73
52-week low
$0.62
Average daily volume
5M
Financial strength
Current ratio
7.452
Quick ratio
7.248
Long term debt to equity
58.58
Total debt to equity
59.309
Interest coverage (TTM)
-12.32%
Management effectiveness
Return on assets (TTM)
-44.16%
Return on equity (TTM)
-136.09%
Valuation
Price to revenue (TTM)
39.263
Price to book
1.43
Price to tangible book (TTM)
1.9
Price to free cash flow (TTM)
-0.985
Growth
Revenue change (TTM)
886.60%
Earnings per share change (TTM)
-2.41%
3-year revenue growth (CAGR)
121.22%
3-year earnings per share growth (CAGR)
15.21%
What the Analysts think about LXRX
Analyst Ratings
LXRX Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
LXRX Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
LXRX News
FAQs
What’s the current market cap for Lexicon Pharmaceuticals stock?
What is the P/E ratio for Lexicon Pharmaceuticals stock?
Does Lexicon Pharmaceuticals stock pay dividends?
No, Lexicon Pharmaceuticals (LXRX) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Lexicon Pharmaceuticals dividend payment date?
Lexicon Pharmaceuticals (LXRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals (LXRX) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.